GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Bioscience International Holdings Inc (OTCPK:CBIH) » Definitions » Pretax Margin %

CBIH (Cannabis Bioscience International Holdings) Pretax Margin % : -42.46% (As of Aug. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Bioscience International Holdings Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Cannabis Bioscience International Holdings's Pre-Tax Income for the three months ended in Aug. 2024 was $-0.08 Mil. Cannabis Bioscience International Holdings's Revenue for the three months ended in Aug. 2024 was $0.18 Mil. Therefore, Cannabis Bioscience International Holdings's pretax margin for the quarter that ended in Aug. 2024 was -42.46%.

The historical rank and industry rank for Cannabis Bioscience International Holdings's Pretax Margin % or its related term are showing as below:

CBIH' s Pretax Margin % Range Over the Past 10 Years
Min: -325.87   Med: -66.84   Max: 17.02
Current: -153.52


CBIH's Pretax Margin % is ranked worse than
90.06% of 996 companies
in the Drug Manufacturers industry
Industry Median: 5.225 vs CBIH: -153.52

Cannabis Bioscience International Holdings Pretax Margin % Historical Data

The historical data trend for Cannabis Bioscience International Holdings's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Bioscience International Holdings Pretax Margin % Chart

Cannabis Bioscience International Holdings Annual Data
Trend Dec06 Dec07 May09 May10 May11 May23 May24
Pretax Margin %
Get a 7-Day Free Trial 16.57 -17.01 17.02 -325.87 -261.45

Cannabis Bioscience International Holdings Quarterly Data
May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -249.32 -193.75 -580.56 -178.95 -42.46

Competitive Comparison of Cannabis Bioscience International Holdings's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Bioscience International Holdings's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Bioscience International Holdings's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Bioscience International Holdings's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Cannabis Bioscience International Holdings's Pretax Margin % falls into.



Cannabis Bioscience International Holdings Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Cannabis Bioscience International Holdings's Pretax Margin for the fiscal year that ended in May. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: May. 2024 )/Revenue (A: May. 2024 )
=-0.651/0.249
=-261.45 %

Cannabis Bioscience International Holdings's Pretax Margin for the quarter that ended in Aug. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Aug. 2024 )/Revenue (Q: Aug. 2024 )
=-0.076/0.179
=-42.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Bioscience International Holdings  (OTCPK:CBIH) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Cannabis Bioscience International Holdings Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Cannabis Bioscience International Holdings's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Bioscience International Holdings Business Description

Traded in Other Exchanges
N/A
Address
6201 Bonhomme Road, Suite 435N, Houston, TX, USA, 77036
Cannabis Bioscience International Holdings Inc provides educational systems focused on medical cannabis in cities throughout the United States and six countries in Latin America. The company provides services in therapeutic areas of clinical trials and services relating to sleep disorders through its sleep center in Houston, Texas. It offered concierge medicine at an affordable price through a membership-based model through its wholly-owned subsidiary.

Cannabis Bioscience International Holdings Headlines

From GuruFocus

CHNC Saga, Metamorphosis, and Transformation

By Marketwired Marketwired 02-05-2021

CHNC Completes Review of Its First Three Fiscal Quarters

By PurpleRose PurpleRose 07-12-2022